Member Contact: Marieta Ryan
Position: Director, Australia
Industry: Biotech & Pharmaceuticals
AlgiPharma AS is a clinical stage pharmaceutical company founded in August 2006, based on research and development carried out by FMC BioPolymer AS and the Biopolymer Foundation at the Norwegian University of Science and Technology in Trondheim, Norway.
AlgiPharma’s aim is to address unmet medical needs, fighting diseases effectively through its innovative alginate oligomer technologies, by developing products and therapies to market or license to suitable partners.
AlgiPharma AS owns or licenses all relevant patents upon which the technology platform and products are developed.
AlgiPharma is supported by national and international research programs and grants, and collaborates with a network of key opinion leaders, highly recognized academic institutions, research and patient organizations in Europe, USA, and Australasia.